News Snapshot:
NEWS Beijing, Mar 1 China concluded the registration of four Covid-19 vaccines in February that were approved to enter the market officially, but at the same time it reinforced its fight against those who counterfeit and trade those vaccines. The vaccines made by CanSino Biologics and Sinopharm were the last to be endorsed by the National Medical Products Administration for commercialization under certain conditions. Previously, only Sinovac’s CoronaVac vaccine and Sinopharm CNBG had been certified, which implies a strict supervision of the quality and safety of the medicines from the manufacture to the administration of each dose. CanSino’s vaccine is...
